RARA CRAFT DATABASE for FDA Medical Devices
510(k)K233505

FDA DEVICE FACTS

Sapphire ULTRA Coronary Dilatation Catheter

OrbusNeich Medical (Shenzhen) Co., Ltd.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEAugust 15, 2024PRODUCT CODELOX

Indications for use

The indication for use for Sapphire ULTRA Coronary Dilatation Catheter remains the same as the predicate device (Sapphire II PRO): The Sapphire U LTRA Coronary Dilatation Catheter (1.0 -1.25mm configurations) is indicated for: ⚫ balloon pre-dilatation of a stenotic portion of a coronary artery or bypass graft stenosis (≥70% stenosis) for the purpose of improving myocardial perfusion. The Sapphire U LTRA Coronary Dilatation Catheter (1.5 -4.0mm configurations) is indicated for: ⚫ balloon dilatation of the stenotic portion of a coronary artery or bypass graft stenosis in patients evidencing coronary ischemia for the purpose of improving myocardial perfusion. ⚫ balloon dilatation of a coronary artery occlusion for the treatment of acute myocardial infarction

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 16, 2026